Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/132965
Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Background: a higher risk of atherothrombotic cardiovascular events, which are platelet-driven processes, has been described during acute exacerbations of chronic obstructive pulmonary disease (AECOPD). However, the relevance of platelet reactivity during AECOPD and whether this is affected by antiplatelet agents are not fully elucidated to date. This study aimed to evaluate whether platelet reactivity is augmented during an exacerbation in COPD patients with and without antiplatelet therapy and its association with systemic inflammatory parameters. Materials and methods: prospective, observational, ex vivo investigation was conducted in consecutive patients suffering an exacerbation of COPD. Platelet reactivity was assessed during AECOPD and at stable state. Platelet function assays included: 1) vasodilator-stimulated phosphoprotein assay expressed as P2Y12 reactivity index (PRI), 2) multiple electrode aggregometry and 3) optical aggregometry. Systemic inflammatory parameters such as leukocyte count, interleukin-6 and fibrinogen were also assessed. Results: higher platelet reactivity was observed during AECOPD compared to stability measured by vasodilator-stimulated phosphoprotein (PRI: 75.2%±1.9% vs 68.8%±2.4%, p=0.001). This augmented platelet aggregability was also observed in the subset of patients on antiplatelet therapy (PRI: 72.8%±3.1% vs 61.7%±7.5%, p=0.071). Consistent findings were observed with all other platelet function tests. Patients with greater enhancement of inflammatory markers during AECOPD were more likely to present a higher increase in platelet reactivity. Conclusion: platelet reactivity is increased during AECOPD, which may contribute to the augmented cardiovascular risk of these patients. Additionally, the increase in platelet reactivity might be associated with an increment in inflammatory markers during exacerbations.
Matèries (anglès)
Citació
Citació
MUÑOZ ESQUERRE, Mariana, FERREIRO, José luis, HUERTAS, David, MARCANO, Ana lucrecia, LÓPEZ SÁNCHEZ, Marta, ROURA I FERRER, Gerard, GÓMEZ HOSPITAL, Joan antoni, DORCA I SARGATAL, Jordi, CEQUIER FILLAT, Àngel r., SANTOS PÉREZ, Salud. Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients. _International Journal of Chronic Obstructive Pulmonary Disease_. 2017. Vol. 2018, núm. 13, pàgs. 141-148. [consulta: 26 de gener de 2026]. ISSN: 1176-9106. [Disponible a: https://hdl.handle.net/2445/132965]